参考文献/References:
[1]Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362:1090-1101.
[2]管珩,刘志民,李光伟,等.50岁以上糖尿病病人群周围动脉闭塞性疾病相关因素分析.中华医学杂志,2007,87(1):23-27.
[3]潘长玉,高妍,袁申元,等.2型糖尿病下肢血管病变发生率及相关因素调查.中国糖尿病杂志,2001,9(6):323-326.
[4]谷涌泉,张建,齐立行,等.糖尿病下肢动脉粥样硬化特点及相关因素的研究. 中华老年多器官疾病杂志,2007,6(4):266-268.
[5]齐立行,谷涌泉,俞恒锡,等.糖尿病与非糖尿病性动脉硬化下肢血管造影特点及其临床意义. 中华糖尿病杂志,2005,6:412-416.
[6]许樟荣,敬华译,钱荣立校.糖尿病足国际临床指南.北京:人民军医出版社,2003.6-9.
[7]Zeller T,Frank U,Bürgelin K, et al. Initial experience with percutaneous atherectomy in the infragenicular ateries. J Endovasc Ther,2003,10:987-993.
[8]Zeller T, Rastan A, Schwarzwalder U, et al. Longterm results after directional atherectomy of femoropopliteal lesions with the SilverHawk catheter. J Am Coll Cardiol,2006,48:1573-1578.
[9]McKinsey JF, Goldstein L, Khan HU, et al. Novel treatment of patients with lower extremity ischemia: Use of percutaneous atherectomy in 579 lesions. Ann Surg,2008,248:519-528.
[10]谷涌泉,郭连瑞,佟铸,等.SilverHawk治疗长段股总动脉和股浅动脉支架内再狭窄一例.中华普通外科杂志,2011,26(3):265-266.
[11]姜宏,钱均,阎浩,等.直接斑块切除治疗股腘动脉闭塞性病变.中华普通外科杂志,2011,26(3):180-183.
[12]McQuade K, Gable D, Pearl G,et al. Fouryear randomized prospective comparison of percutaneous ePTFE/nitinol selfexpanding stent graft versus prosthetic femoralpopliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg,2010,52(3):584-590.
[13]Bosiers M, Deloose K, Keirse K, et al. Are drugeluting stents the future of SFA treatment? J Cardiovasc Surg (Torino), 2010,51(1):115-119.